Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice [Corrigendum]

Abstract

Zhao Y, Wang H, Yang Y, et al. Int J Nanomedicine. 2020:15:9571–9586 The authors have advised Figure 4F on page 9579 is incorrect. Due to an error at the time of figure assembly the representative image from free E7/CpG group twice instead the image of Lip E7/CpG. The correct Figure 4 is shown below. The authors apologize for this error and advise it does not affect the results of the paper. Read the original article

Keywords

• immunotherapy
• human papillomavirus
• peptide vaccine
• cpg odn adjuvant
• liposome
• tumor microenvironment